The transforming growth factor-betas. A new family of immunoregulatory molecules (Q34042442)

30 July 2017

1 reference

title

The transforming growth factor-betas. A new family of immunoregulatory molecules (English)

1 reference

30 July 2017

Palladino MA

1

1 reference

30 July 2017

Morris RE

series ordinal

2

1 reference

30 July 2017

Starnes HF

series ordinal

3

1 reference

30 July 2017

Levinson AD

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 1990

1 reference

Annals of the New York Academy of Sciences

30 July 2017

1 reference

30 July 2017

593

1 reference

30 July 2017

181-187

1 reference

Some recent advances in the chemistry and biology of transforming growth factor-beta

30 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Identification of another member of the transforming growth factor type beta gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Beta transforming growth factors are potential regulators of B lymphopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

TGF-beta inhibits the in vitro induction of lymphokine-activated killing activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Transforming growth factor-beta s are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Active and latent forms of transforming growth factor beta activity in synovial effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

Deactivation of macrophages by transforming growth factor-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16110.X

10.1111/J.1749-6632.1990.TB16110.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference